A phase II, multicenter, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the safety and efficacy of HAE1 (PRO98498) in subjects with moderate to severe allergic asthma

Trial Profile

A phase II, multicenter, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the safety and efficacy of HAE1 (PRO98498) in subjects with moderate to severe allergic asthma

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Oct 2015

At a glance

  • Drugs PRO 98498 (Primary)
  • Indications Allergic asthma
  • Focus Therapeutic Use
  • Sponsors Genentech
  • Most Recent Events

    • 01 Jan 2008 Status changed from in progress to completed.
    • 15 Jun 2007 Status changed from suspended
    • 27 Apr 2007 Status changed from recruiting
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top